Industry Experts

Dr. Varsha Sundaresan is currently a Clinical Biomarker Lead in the Oncology Precision and Translational Medicine group at Takeda Pharmaceuticals, Cambridge MA. Varsha has expertise in developing and implementing biomarker strategy for Immuno-oncology studies in solid and liquid tumors, various stages of clinical development and multiple therapeutic modalities. Prior to Takeda, she was a Translational Medicine Lead at Rubius Therapeutics. She received her PhD in Medical Sciences from University of Florida and has 5+ years of experience in clinical biomarkers, cancer genomics and translational medicine.